PTX 2.50% 4.1¢ prescient therapeutics limited

Ann: Appendix 3B, page-9

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,656 Posts.
    lightbulb Created with Sketch. 198
    Not sure sam_wells if your question was aimed at advantages/disadvantages of the unlikely event of the options being converted or not.
    Again simply for the flow of this thread, the answer is both.
    For example, the options were offered free of charge to holders that participated in the 9 cent CR, approximately a year and three months ago.
    If they reach maturity, then another approx 55mil of shares will be added to the current registry (approx 210mil). So dilution for only those that either didn’t contribute to the CR or those that sold part or all of allocated amount.
    Note, there is still some dilution overall regardless of holders or not due to the ratio factor (can’t remember if hand, think it was 1-2). At work now so maybe someone can answer better on ratio.
    The upside of course is another approx $10 million of funds available added to the existing kitty of approx $6 million.
    Needless to say, a definite bonus towards current trials and proposed alike.
    Hope that helps.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.